November, 2016

article thumbnail

The Patient Centric Launch – business insights key to success in Europe

pharmaphorum

Join us and PHOENIX group as we delve into the concept of current launch excellence and the role of patient insights in overcoming the multiple challenges the industry currently faces. Key topics to be discussed include: – The challenges of launching a product in Europe – How pharma can improve its understanding of the process through the use of business intelligence – How insights from new data can be applied to the process of launch excellence – The role of real-world data in launch strategy –

article thumbnail

The first paid research subject in written history?

Placebo Control

On this date 349 years ago, Samuel Pepys relates in his famous diary a remarkable story about an upcoming medical experiment. As far as I can tell, this is the first written description of a paid research subject. According to his account , the man (who he describes as “a little frantic”) was to be paid to undergo a blood transfusion from a sheep. It was hypothesized that the blood of this calm and docile animal would help to calm the man.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Demand Assessment Research: adopting insights from behavioural economics

pharmaphorum

Over the past 20 years, behavioural economics has identified factors that influence and determine how people behave, including alternative decision-making pathways and many cognitive biases and heuristics. Taking account of these helps to build a clear view of how healthcare customers think and behave in relation to your product in the real world. This short masterclass explores ‘quantitative demand assessment research’ – what it is and how insights from behavioural economics can improve the app

article thumbnail

The hepatitis C conundrum: balancing cost and affordability

pharmaphorum

Working with QuintilesIMS, we present a digital debate which will offer modellling-based insights into the future of hepatitis C treatment.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Finding a cure: Getting the best Brexit deal for Britain's life sciences

pharmaphorum

Senior level expert panel debate on the likely impacts of a hard v soft Brexit for life sciences companies in Britain.